New BTK Bioresorbable Stent Technology: Life BTK, The MOTIV-BTK Trial and R3 Clinical Programs

Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:

• Consultant Fee/Honoraria/Speaker's Bureau - Boston Scientific Corporation; Cordis Corporation, a Johnson & Johnson company
• Grant Support/Research Contract - Pfizer